Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine
- PMID: 4468852
- PMCID: PMC1553997
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine
Abstract
Lymphoid subpopulations in the blood and rectal mucosa were studied in six patients with ulcerative colitis or Crohn's disease who had been treated for over three years with azathioprine. Serial assays were performed to observe the changes occurring up to 12 weeks after treatment with azathioprine was stopped. While the patients were on the drug two lymphoid populations showed marked depression. These were the plasma cells of the rectal lamina propria, and blood lymphocytes with cytotoxic activity against antibody-sensitized target cells (`K' cells). After stopping azathioprine, both populations showed a rapid rise to reach near normal levels by 12 weeks. Most of the recovery occurred within 3–5 weeks. There was no significant change in circulating immunoglobulin-staining cells which could be attributed to the drug. Nor was azathioprine shown to have any effect on the mitotic response of lymphocytes to phytohaemagglutinin. Three patients, however, gave very low or erratic responses to PHA, which may have been related either to their disease or to steroid therapy. These results are discussed in relation to the mode of action of purine analogues as immunosuppressive agents.
Similar articles
-
Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.Clin Exp Immunol. 1976 May;24(2):249-58. Clin Exp Immunol. 1976. PMID: 776464 Free PMC article. Clinical Trial.
-
The immunology of inflammatory bowel disease.Henry Ford Hosp Med J. 1982;30(1):25-32. Henry Ford Hosp Med J. 1982. PMID: 6123493 Review. No abstract available.
-
Proceedings: Immunosuppressive consequences of the treatment of ulcerative colitis with azathioprine.Gut. 1974 Oct;15(10):828-9. Gut. 1974. PMID: 4611752 Clinical Trial. No abstract available.
-
Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitis.Z Gastroenterol. 1994 Sep;32(9):483-7. Z Gastroenterol. 1994. PMID: 7801653
-
[Chronic inflammatory bowel diseases: immunologic changes--cause or epiphenomenon?].Z Gastroenterol Verh. 1989 Jul;24:26-30. Z Gastroenterol Verh. 1989. PMID: 2474975 Review. German. No abstract available.
Cited by
-
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.Br Med J. 1974 Dec 14;4(5945):627-30. doi: 10.1136/bmj.4.5945.627. Br Med J. 1974. PMID: 4441827 Free PMC article. Clinical Trial.
-
Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease.World J Gastroenterol. 2017 May 14;23(18):3240-3251. doi: 10.3748/wjg.v23.i18.3240. World J Gastroenterol. 2017. PMID: 28566883 Free PMC article.
-
A practical guide to the management of distal ulcerative colitis.Drugs. 1998 Apr;55(4):519-42. doi: 10.2165/00003495-199855040-00004. Drugs. 1998. PMID: 9561342 Review.
-
[Neuromuscular complications of SARS-CoV-2 infection-Part 2: muscle disorders].Nervenarzt. 2021 Jun;92(6):548-555. doi: 10.1007/s00115-021-01093-1. Epub 2021 Mar 29. Nervenarzt. 2021. PMID: 33779772 Free PMC article. Review. German.
-
The distribution of mucosal antibodies in the bowel of patients with Crohn's disease.Gut. 1975 Feb;16(2):125-31. doi: 10.1136/gut.16.2.125. Gut. 1975. PMID: 1092601 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources